Blue Water Ventures International Inc (OP:BWVI)

0.0004 UNCHANGED

Last Price Updated: 9:47 AM EST, Jan 27, 2026 Add to My Watchlist

Price and Volume

Volume	0
Open	0.0004
Bid (Size)	N/A (0)
Ask (Size)	N/A (0)
Prev. Close	0.0004
Today's Range	0.0004 - 0.0004
52wk Range	0.0001 - 0.0153
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

I Saw Trillions Of Atoms In My Hand Vibrating At A Certain Frequency, Says Zappy Zapolin Describing His First Psychedelics Experience ↗

August 13, 2024

Via Benzinga

Historical Regulatory Filing Deficiences Continue to Stifle Psycheceutical Biosciences

May 16, 2024

Via ACCESSWIRE

Performance

YTD	+300.0%	+300.0%
1 Month	+300.0%	+300.0%
3 Month	+33.3%	+33.3%
6 Month	+100.0%	+100.0%
1 Year	+300.0%	+300.0%

More News

Psychedelics 2024: Veterans Blessing, Mental Health Paradigm Shift, Providers Training, Ketamine-MDMA Bonds & More ↗

March 06, 2024

Via Benzinga

Podcast - Post-Frenzy Psychedelics Investing And Reclaiming The Right To Pursue Happiness With Zappy Zapolin: '2024 Is When It Goes Mainstream' ↗

February 29, 2024

Via Benzinga

Psycheceutical Bioscience Strategically Pivots Into the Brain-Computer Interface (BCI) Space

January 17, 2024

Via ACCESSWIRE

Dr. Neilank Jha Appointed as Executive Chairman and Chief Executive Officer of Psycheceutical Bioscience Inc.

December 12, 2023

Via ACCESSWIRE

Psycheceutical Bioscience Launches Wefunder Crowdfunding Campaign for Safer Psychedelic Dosing

November 01, 2023

Via ACCESSWIRE

Shark Tank's Kevin Harrington Leads Crowdfunding Campaign For Psycheceutical Bioscience (OTCPK: BWVI) ↗

November 06, 2023

Via Benzinga

Treating PTSD Topically & Directly To The Brain? Psychedelics Delivery Company Poised For Major Breakthrough ↗

September 03, 2023

Via Benzinga

Psycheceutical Announces Successful First Cohort Dosing; Moves to Dose Escalation in Phase I Trial of NeuroDirect Ketamine for PTSD

August 10, 2023

Via ACCESSWIRE

Psycheceutical Bioscience Announces Completion of PCAOB Audit and Future Corporation Action Strategy

August 01, 2023

Via ACCESSWIRE

First Patient Dosed in Psycheceutical's Phase I Study Exploring Topical Administration of Ketamine to Treat PTSD

July 13, 2023

Via ACCESSWIRE

Video: 'Moms On Mushrooms Are Gonna Change The Whole Society,' Says Zappy Zapolin Before Presenting Rick Doblin Award ↗

June 23, 2023

Via Benzinga

EXCLUSIVE: Lessons From Psychedelics Markets Through Business, Legal And Reciprocity Lenses ↗

May 12, 2023

Via Benzinga

Zappy Zapolin Talks Psychedelics And Breakthrough Delivery Methods: The Future Has Arrived And It's Awesome ↗

May 03, 2023

Via Benzinga

The Next Generation Of Mental Health Treatment: Psycheceutical Bioscience Inc.’s (OTCPK:BWVI) Novel Topical Ketamine Delivery

April 18, 2023

Via ACCESSWIRE

Psyched: MDMA Therapy Advances With FDA, Alternatives For Alcohol Addiction, Prince Harry In The Spotlight And More ↗

April 11, 2023

Via Benzinga

This Groundbreaking Ketamine Topical Cream Is Capturing Rick Doblin's Attention ↗

April 05, 2023

Via Benzinga

What To Expect From The Benzinga Psychedelics Capital Conference, The Must-Attend Event For This Emerging Industry ↗

April 03, 2023

Via Benzinga

Psycheceutical Hosts MAPS Founder and Psychedelic Industry Leader Rick Doblin at Its Drug Development Lab

March 29, 2023

From Psycheceutical Bioscience, Inc.

Via GlobeNewswire

What If There Was A Topical Cream That Treated PTSD Without Side Effects? — Psycheceutical Bioscience, Inc (OTCPK: BWVI) Is Pioneering A Possible Solution

March 29, 2023

Via News Direct

What If There Was A Topical Cream That Treated PTSD Without Side Effects? — Psycheceutical Bioscience, Inc (OTCPK: BWVI) Is Pioneering A Possible Solution

March 29, 2023

Via TheNewswire.com

Psyched: Australia As Psychedelics Hub, Advanced Scans Of Brain On DMT, New PAC For Congressional Influence, 9 States Advancing Bills & More ↗

March 27, 2023

Via Benzinga

Breakthrough Treatment For PTSD? This Ketamine Cream Showing Promise In Alleviating Symptoms ↗

March 22, 2023

Via Benzinga

Psycheceutical Bioscience, Inc. Announces Observational Research Results for NeuroDirect™ Ketamine Topical Cream in Treating PTSD

March 21, 2023

From Psycheceutical Bioscience, Inc.

Via GlobeNewswire

Frequently Asked Questions

Is Blue Water Ventures International Inc publicly traded?

Yes, Blue Water Ventures International Inc is publicly traded.

What exchange does Blue Water Ventures International Inc trade on?

Blue Water Ventures International Inc trades on the OTC Traded

What is the ticker symbol for Blue Water Ventures International Inc?

The ticker symbol for Blue Water Ventures International Inc is BWVI on the OTC Traded

What is the current price of Blue Water Ventures International Inc?

The current price of Blue Water Ventures International Inc is 0.0004

When was Blue Water Ventures International Inc last traded?

The last trade of Blue Water Ventures International Inc was at 01/27/26 09:47 AM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.